Bioprocessing technologies company Repligen is acquiring Avitide, and its biologics purifying technology, in a $150 million cash and stock deal. Repligen said Avitide will help it meet growing demand for gene therapy solutions.
In an article published in the journal mAbs Monday, executives from Adimab alleged that MIT's Ram Sasisekharan copied prior monoclonal antibody research. Visterra, a company Sasisekharan founded that had been developing one of the antibodies, was acquired by Otsuka for $430M last year.
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.
PillPack has set itself apart, particularly with its customer-centered approach to disrupt the traditional pharmacy model and now Walmart is engaging the company in acquisition talks, according to CNBC.
"[I]f we don't get tough on the drug dealers, we're wasting our time," Trump said in New Hampshire on March 19. "And that toughness includes the death penalty." In his remarks, the president also outlined other aspects of the administration's plan to fight the opioid crisis, such as confronting overprescribing.
When it's time to connect a new device, the user points the "magic wand" toward the device to beam secret network information.
Avitide, a New Hampshire biotech startup, just raised a $7.5 million Series C for its lithe protein engineering platform that can purify and develop biologics and biosimilars.
FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.
Vapotherm's breathing tubes humidify and heat respiratory gases to make breathing easier for patients with conditions like asthma, COPD and congestive heart failure.
Compass Therapeutics, formed by leadership at fellow antibody discovery company Adimab, is raising $120 million.
Brain tumors are usually treated with an intense course of cancer’s Big Three: Surgery, radiation and heavy chemotherapy. Medical device startup Novocure is adding a new treatment option into the mix: Electrofield therapy, in which alternating electric fields shut down cellular division – curbing the growth of cancer. It’s called Optune. And it seems to be wildly […]
A breast cancer diagnostics startup that offers an ancillary imaging system to use on top of standard mammography just raised $6.5 million, according to regulatory filings. New Hampshire-based Gamma Medica has developed a tool, called the LumaGEM, that’s meant as a secondary diagnostic tool for women with dense breast tissue. It’s more difficult for mammograms to discern the […]
Help shape the future of healthcare benefits by sharing your insights.
PillPack, a medication adherence business that was born at an MIT hacking medicine weekend, has raised a Series B round partly to boost its sales and marketing muscle through direct to consumer ads. CEO and co-founder TJ Parker told MedCity News in a phone interview that it’s testing its ability to reach customers offline through […]
Robots and a good sense of design have changed the way pharmacist TJ Parker works – and the way his customers manage their prescriptions. Today he and co-founder Elliot Cohen are launching PillPack, a mail-order pharmacy aimed at making it less burdensome for people to manage their medications, and hopefully more likely that they’ll take […]
Are women shaking up angel investment? That could be one conclusion made from a new report showing that the proportion of active women angel investors allocating funds to healthcare and biotechnology, among other sectors, nearly doubled in 2012. Angel investors who are women rose from 11 percent in 2011 to 22 percent in 2012, according […]
A medical device manufacturer that has specialized in developing humidification systems to improve breathing for people with respiratory difficulties such as asthma, croup and COPD has raised $26.4 million, according to a Form D filing with the U.S. Securities and Exchange Commission. Last year, Vapotherm, which has offices in Stevensville, Maryland, said it would expand […]
A new treatment for a deadly form of brain cancer has been approved by the FDA and is cleared for sale in the U.S. market. The NovoTTF-100A System (NovoTTF) made by NovoCure is a “non-invasive device consisting of four sets of insulated electrodes attached to an electronic box,” according to the privately-held Israeli company. The […]